Global Cell and Gene Therapy CDMO Market Size, Share, Growth & Trends Report Segmented by Service Type (Clinical Development, Commercial Manufacturing), Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), Indication & Regional Forecast to 2031

This report by Medi-Tech Insights provides the size of the global cell and gene therapy CDMO market at the regional- and country-level from 2023 to 2030. The report further segments the market based on service type, product type and indication.

Market Size & Forecast (2023-2030), By Service Type, USD Million

• Clinical Development
• Commercial Manufacturing

Market Size & Forecast (2023-2030), By Product Type, USD Million

• Gene Therapy
  • Ex-vivo
  • In-vivo
• Cell Therapy
• Gene-Modified Cell Therapy
  • CAR T-cell therapies
  • CAR-NK cell therapy
  • TCR-T cell therapy
  • Other

Market Size & Forecast (2023-2030), Indication, USD Million

• Oncology
• Neurological Disorders
• Infectious Diseases
• Rare Diseases
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa